EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin

Yasushi Kubota iD, Shinya Kimura

International Journal of Molecular Sciences · 16.01.2026 · 27 (2) · 915

DOI: 10.3390/ijms27020915 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.01.2026. Verfasst von Yasushi Kubota und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Saga-Ken Medical Centre Koseikan, Saga 840-8571, Japan. Hauptthemen laut MEDLINE: 2-Hydroxypropyl-beta-cyclodextrin, Antineoplastic Agents, Water. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclodextrins (CyDs) are cyclic oligosaccharides that form inclusion complexes that allow organic compounds and other substances to be incorporated into their cavities. Hydroxypropyl-β-cyclodextrin (HP-β-CyD) is frequently used to improve the formulation properties of poorly water-soluble drugs because of its aqueous solubility and biocompatibility. Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with HP-β-CyD, which in some cases enhances their anticancer activity relative to the unmodified drugs. Advances in formulation strategies have enabled more efficient intracellular delivery, improved tissue and cell selectivity, and controlled release. HP-β-CyD has also been investigated as an active pharmaceutical ingredient, with demonstrated efficiency in treating leukemia and breast cancer. For example, folate-conjugated HP-β-CyD exhibits high selectivity for folate receptor-expressing cells and more potent anti-cancer activity than unmodified HP-β-CyD. Autophagy has been suggested to be involved in this mechanism. The continued development of drug-delivery systems that integrate advanced technologies and materials based on HP-β-CyD holds promise for further advances in cancer therapy. These findings indicate a paradigm shift in the role of HP-β-CyD from a formulation additive to an active pharmaceutical ingredient, suggesting broader applications for HP-β-CyD in anticancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

2-Hydroxypropyl-beta-cyclodextrinAntineoplastic AgentsWaterHumansSolubilityAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

active pharmaceutical ingredientautophagycancercholesterolcyclic oligosaccharidedrug delivery systemfolate receptorleukemia

Substanzen

2-Hydroxypropyl-beta-cyclodextrinAntineoplastic AgentsWater

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Saga-Ken Medical Centre Koseikan, Saga 840-8571, Japan.
  • Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.

ORCID-Profile: Yasushi Kubota

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kubota, Y., & Kimura, S. (2026). Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin. International Journal of Molecular Sciences, 27(2), 915. https://doi.org/10.3390/ijms27020915

Vancouver

Kubota Y, Kimura S. Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin. International Journal of Molecular Sciences. 2026;27(2):915. doi:10.3390/ijms27020915

BibTeX
@article{Kubota2026,
  author = {Kubota, Yasushi and Kimura, Shinya},
  title = {Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {915},
  doi = {10.3390/ijms27020915}
}
Kostenlos starten →